Neuroimaging in Wilson disease

Metabolic Brain Disease

Volumn 12, Issue 1, 1997, Pages 1-19

  Van Wassenaer van Hall, Hester N ^a  

^a Zuwe Hofpoort Ziekenhuis   (Netherlands)

Author keywords

brain; CT; MRI; pathology; Wilson disease

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; COPPER METABOLISM; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WILSON DISEASE;

EID: 0030936738     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02676350     Document Type: Review

References (119)

1. Aisen, A.M., Martel, W., Gabrielsen, T.O., Glazer, G.M., Brewer, G., Young, A.B., and Hill, G. (1985). Wilson Disease of the Brain: MR Imaging. Radiology 157:137-141.
2. Aoki, S., Okada, Y., Nishimura, K., Barkovich, A.J., Kjos, B.O., Brasch, R.C., and Norman D. (1989). Normal Deposition of Brain Iron in Childhood and Adolescence: MR Imaging at 1.5 T. Radiology 172:381-385.
3. Barbosa, E.R., Comerlatti, L.R., Scalff, M., and Canelos, H.M. (1985). Degegeracao hepato-lenticular: aspectos diagnosticos em 95 casos. Arq. Neuropsiq. 43(3):234-242.
4. Barkovich, A.J. (1990). Hallervorden-Spatz Disease. In (A.J. Barkovich, ed) Pediatric Neuroimaging Vol. 1 Contempory Neuroimaging, Raven Press, New York, 48-49.
5. Barnes, S., and Hurst, E. W. (1926). A further note on hepato-lenticular degeneration. Brain 49:36-60.
6. Bisese, J.H., and Wang, A.M. (1994). Wilson disease: In (J.H. Bisese, and A.M. Wang, eds) Pediatric Cranial MRI, Springer-Verlag, New York: p. 133.
7. Bloemberger, N., and Morgan, L.O. (1961). Influence of copper on T1 and T2 relaxation times. J. Chem. Phys. 34:842.
8. Brewer, G.J., Terry, C.A., Aisen, A.M., and Hill, G.M. (1987). Worsening of neurological syndrome in patients with Wilson's Disease with initial penicillamine therapy. Arch. Neurol. 44:490-492.
9. Brewer, G.J., Yuzbasiyan-Gurkan, V., Lee, D.Y., and Appelman, H. (1989). Treatment of Wilson's disease with zinc. VI. Initial treatment studies. J. Lab. Clin. Med. 114(6):633-638.
10. Brewer, G.J., and Yuzbasiyan-Gurkan, V. (1992). Wilson Disease. Medicine 71:139-164.
11. Brewer, G.J., Dick, R.D. Johnson, V., Wang, Y., Yuzbasiyan-Gurkan, V., Kluin, K., Fink, J.K., and Aisen, A. (1994). Treatment of Wilson's Disease with ammonium tetrathiomolybdate. Arch. Neurol. 51:545-554.
12. Brewer, G.J. (1995). Treatment of neurologic manifestations of Wilson's disease (letter). Arch. Neurol. 52:340.
13. Brugeries, P., Combes, C., Ricolfi, F., Degos, J.D., Poirier, J., and Gaston A. (1992). Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper? Neuroradiology 34:222-224.
14. Bull, P.C., Thomas, G.R., Rommens, J.M., Förbes, J.R., and Cox, D.W. (1993). The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5:327-337.
15. Carpenter, TO, Carnes, DL, and Constantine, S. (1983). Hypoparathyroidism in Wilson's disease. N. Engl. J. Med. 309:873-877.
16. Cartwright, G.E., Hodges, R.E., Gubler, C.J., Mahoney, J. Wintrobe, M.M., and Bean W.B. (1954). Studies on copper metabolism. XIII. Hepatolenticular degeneration. J. Clin. Invest. 33:1487-1501.
17. Chen, X.R., Shen, T.Z., Li, N.Z., and Liu, D.K. (1983). Computed tomography in hepatolenticular degeneration (Wilson's disease). Comput. Radiol. 7(6):361-364.
18. Chu, N.S. (1989). Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement. Clin. Neurol. Neurosurg. 91(1): 45-51.
19. Cumings, J.N. (1948). The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 71:410-415.
20. Cumings, J.N. (1968). Trace metals in the brain and in Wilson's disease. J. Clin. Pathol. 21:1-7.
21. Czlonkowska, A., Gajda, J., and Rodo, M. (1995). Comparison of the effect of treatment in Wilson's disease with d-penicillamine and zinc sulphate as an initial therapy (abstract). Z. Gastroenterol. 33:479.
22. Danks, D.M. (1989). Disorders of copper transport. In (C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds). The Metabolic Basis of Inherited Disease, McGraw Hill Information Services Company, New York, pp. 1411-1421.
23. Detorri, P., Rachele, M.G., and Demelia, L. (1984). Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease. Eur. Neurol. 23(1): 56-63.
24. De Haan, J., Grossman, R.I., Civitello, L., Hackney, D.B., Goldberg, H.I., Bilaniuk, L.T., and Zimmerman, R.A. (1987). High-field magnetic resonance imaging of Wilson's disease. J. Comput. Tomography 11:132-135.
25. Dixon, A.K., and Walshe, J.M. (1984). Computed tomography of the liver in Wilson's disease. J. Comput. Assisted Tomography 8(1): 46-49.
26. Dornemann, H., Petsch, R., and Braitinger, S. (1987). MRI bei Morbus Wilson. Fortschr. Rontgenstr. 147(5): 570-571.
27. Drayer, B.P. (1989). Basal ganglia: significance of signal hypointentsity on T2-weighted MR images. Radiology 173:311-312.
28. Drayer, B.P. (1995). Degenerative disorders of the central nervous system: an integrated approach to the differential diagnosis. Neuroimaging Clin. North Am. 5(1):135-153.
29. Duchen, L.W., and Jacobs, J.M. (1992). Familial hepatolenticular degeneration (Wilson's disease). In (J.H. Adams, and L.W. Duchen, eds), Greenfield's Neuropathology, 5th ed., Edward Arnold, London, pp. 838-841.
30. Earl, C.J. (1961). Anatomical distribution of copper in the brain. In: (J.M. Walshe and J.N. Cummings, eds) Wilson's Disease: Some Current Concepts. Blackwell, Oxford: pp. 18-23.
31. Engelbrecht, V., Schlaug, G., Hefter, H., Kahn, T., and Modder, U. (1995). MRI of the Brain in Wilson Disease: T2 Signal Loss Under Therapy. J. Comput. Assisted Tomography 19(4):635-638.
32. Feng, Y.K. (1957). Wilson's disease. Report of ten cases. Clin. Med. J. 75:631-655.
33. Frydman, M., Bonne-Tamir, B., Farrer, L.A., Conneally, M., Magazanik, A., Ashbel, S., and Goldwitch, Z. (1985). Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus. Proc. Natl. Acad. Sci. USA 82:1819-1821.
34. Glass, J.D., Reich, S.G., and DeLong, M.R. (1990). Wilson's Disease: Development of Neurological Disease After Beginning Penicillamine Therapy. Arch. Neurol. 47:595-596.
35. Greenfield, J.G., Poynton, F.J., and Walshe, F.M.R. (1924). On progressive lenticular degeneration (hepatolenticular degeneration). Q. J. Med. 17:385-403.
36. Grimm, G., Prayer, L., Oder, W., Ferenci, P., Madi, Ch., Knoflach, P. et al. (1991). Comparison of functional and structural brain disturbances in Wilson's disease. Neurology 41:272-276.
37. Harik, S.I., and Donvan Post, J. (1981). Computed tomography in Wilson disease. Neurology 31:107-110.
38. Hawkins, R.A., Mazziotta, J.C., and Phelps, M.E. (1987). Wilson disease studied with FDG and positron emission tomography. Neurology 37:1707-1711.
39. Hefter, H., Rautenberg, W., Kreuzpaintner, G., Arendt, G., Freund, H.-J., Pichlmayr, R., and Strohmeyer, G. (1991). Does orthotopic liver transplantation heal Wilson's disease? Follow-up of two liver-transplanted cases. Acta Neurol. Scand. 84:192-196.
40. Heier, L.A., Bauer, C.J., Schwartz, L., Zimmerman, R.D., Morgello, S., and Deck, M.D.F. (1989). Large Virchow-Robin spaces: MR-clinical correlation. Am. J. Neuroradiol. 10:929-936.
41. Hitoshi, S., Iwata, M., and Yoshikawa, K. (1991). Mid-brain pathology of Wilson's disease: MRI analysis of three cases. J. Neurol. Neurosurg. Psychiatry 54:624-626.
42. Hock, A., Demmel, U., Schicha, H., Kasperek, K., and Feinendegen, L.E. (1975). Trace element concentration in human brain. Brain 98:49-64.
43. Hoogenraad, T.U., and Rothuizen, J. (1986). Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers (letter). Lancet 2:170.
44. Hoogenraad, T.U., Van Hattum, J., and Van den Hamer C.J.A. (1987). Management of Wilson's disease with zinc sulphate: experience in a series of 27 patients. J. Neurol. Sci. 77:137-146.
45. Hoogenraad, T.U. (1996). Major Problems in Neurology, Vol. 30; Wilson's Disease, W. B. Saunders Company, London.
46. Horoupian, D.S., Sternlieb, I., and Scheinberg, LH. (1988). Neuropathological findings in penicillamine-treated patients with Wilson's disease. Clin. Neuropathol. 7(2):62-67.
47. Houwen, R.H.J. (1991). Wilson disease: from clinical to molecular. (Dissertation University of Groningen). Elinkwijk, Utrecht.
48. Huang, C.C., and Chu, N.S. (1992). Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson disease: report of a case. J. Formosan Med. Assoc. 91(6):627-629.
49. Imiya, M., Ichikawa, K., Matsushima, H., Kageyama, Y., and Fujioka, A. (1992). MR of the base of the pons in Wilson Disease. Am. J. Neuroradiol. 13:1009-1012.
50. Ishino, H., Takashi, M., Hayashi, Y., Saito, A., and Otsuki, S. (1972). A case of Wilson's disease with enormous cavity formation of cerebral white matter. Neurology 22:905-909.
51. Kendall, B.E., Pollock, S.S., Bass, N.M., and Valentine, A.R. (1981). Wilson's Disease: Clinical Correlation with Cranial Computed Tomography. Neuroradiology 22:1-5.
52. Kvicala, V, Vymazai, J, and Nevsimalova, S. (1983). Computed tomography of Wilson disease. Am. J. Neuroradiol. 4:429-430.
53. Lang, C.J.G., Rabas-Kolominsky, P., Engelhardt, A., Kobras, G., and Konig, H.J. (1993). Fatal deterioration of Wilson's Disease after institution of oral zinc therapy (letter). Arch. Neurol. 50:1007-1008.
54. Lawler, G.A., Pennock, J.M., Steiner, R.E., Jenkins, W.J., Sherlock, S., and Young, I.R. (1983). Nuclear Magnetic Resonance (NMR) Imaging in Wilson Disease. J. Comp. Ass. Tomography 7(1):1-8.
55. Le Fort, D., Deleplanque, B., Louiset, P., Pautrizel, B., and Loiseau, P. (1988). Maladie de Wilson: Demonstration de lesions corticales et de la substance blanche par IRM. Rev. Neurol. (Paris) 144(5):365-367.
56. Leu, M.L., Strickland, G.T., Wang, C.C., and Chen, T.S.M. (1970). Skin pigmentation in Wilson's disease. J.A.M.A. 211:1542-1543.
57. Linne, T., Agartz, I., Saaf, J., and Wahlund, L.O. (1990). Cerebral abnormalities in Wilson's disease as evaluated by ultra-low-field magnetic resonance imaging and computerized image processing. Magn. Reson. Imaging 8:819-824.
58. Lingam, S., Wilson, J., Nazer, H., and Mowat, A.P. (1987). Neurological Abnormalities in Wilson's Disease are reversible. Neuropediatrics 18:11-12.
59. Lukes, S.A., Aminoff, M.J., Crooks, L., Kaufman, L., Mills, C, and Newton, T.H. (1983). Nuclear magnetic resonance imaging in movement disorders. Ann. Neurol. 13(6):690-691.
60. Luxenberg, M.N. (1987). Magnetic Resonance imaging diagnosis of hepatolenticular degeneration. Arch. Ophthalmol. 105:227.
61. Ma, K.C., Ye, Z.R., Fang, J., and Wu, J.V. (1988). Glial fibrillary acidic protein immunohistochemical study of Alzheimer I and II astrogliosis in Wilson's disease. Acta Neurol. Scand. 78:290-296.
62. Magalhaes, A.C.A., Caramelli, P., Menezes, J.R., Lo, L.S., Bacheschi, L.A., Barbosa, E.R., Rosemberg, L.A., and Magalhaes, A. (1994). Wilson's disease: MRI with clincial correlation. Neuroradiology 36:97-100.
63. Marsden, C.D. (1987). Wilson's disease. Q. J. Med. 65:959-966.
64. Mason, A.L., Marsh, W., and Alpers, D.H. (1993). Intractable neurological Wilson's Disease treated with orthotopic liver transplantation. Dig. Dis. Sci. 38(9):1746-1750.
65. Merland, J.J., Chiras, J., and Melki, J.P. (1978). Etude tomodensitometrique dans la maladie de Wilson. Neuroradiology 16:269-270.
66. Metzer, W.S., and Angtuaco, E. (1986). Long-term followup computed tomography and magnetic resonance imaging findings in hepatolenticular degeneration: Case report and summary of the literature. Mov. Disord. 1(2):145-149.
67. Mirowitz, S.A., Sartor, K., and Gado, M. (1989). High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. Am. J. Neuroradiol. 10:1159-1163.
68. Mirowitz, S.A., Westlich, T.J., and Hirsch, J.D. (1991). Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 181:117-120.
69. Mizutani, N., Maehara, M., Negora, T., Watanabe, K. (1983). Serial changes of cranial computerized tomographic findings in Wilson Disease during D-Penicillamine therapy. Brain Dev. 5(1):48-52.
70. Mzhe'lskaia, T.I. (1989). Analysis of trace elements of the brain and liver tissues in Wilson disease (abstract). Zh. Neuropatol. Psikhiatr. 89(7): 69-73.
71. Nalbandyan, R.M. (1983). Copper in Brain. Neurochem. Res. 8(10): 1211-1232.
72. Nazer, H., Brismar, J, Al-Kawi, M.Z., Gunasekaran, T.S., and Jorulf, K.H. (1993). Magnetic resonance imaging of the brain in Wilson's disease. Neuroradiology 35:130-133.
73. Nelson, R.F., Guzman, D.A., Grahovac, Z., and Howse, D.C.N. (1979). Computerized cranial tomography in Wilson disease. Neurology 29:866-868.
74. Nix, W.A., Ludwig, G., and Backmund, H. (1984). Computertomographische Verlaufsuntersuchungen bei Morbus Wilson. Nervenartz 55(10):544-548.
75. Oder, W., Prayer, L., Grimm, G. Spatt, J., Ferenci, P., Kollegger, H., Schneider, B., Gangl A., Deecke, L. (1993). Wilson disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology 43:120-124.
76. 123I-Iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Ann. Neurol. 32:743-748.
77. Pomier-Layrargues, G., Spahr, L., and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients (letter). Lancet 345:735.
78. Porter, H., and Folch, J. (1957). Brain copper-protein fractions in the normal and in Wilson's Disease. Arch. Neurol. 77:8-16.
79. Prayer, L., Wimberger, D., Kramer, J., Grimm, G., Oder, W., and Imhof, H. (1990). Cranial MRI in Wilson disease. Neuroradiology 32:211-214.
80. Pujol, A., Pujol, J. Graus, F., Rimola, A., Peri, J., Mercader, J.M., Garcia-Pagan, J.C., Bosch, J., Rodes, J., and Tolosa, E. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43:65-69.
81. Roach E.S., Ford C.S., and Soudis E.V. (1985). Wilson's disease: evoked potentials and computed tomography. J. Neurol. 232(1):20-23.
82. Rodiek, S. (1983). Zerebrale Lasionen bie Morbus Wilson im Computertomogramm. Fortschr. Rontgenstr. 139(1):67-71.
83. Roh, J.K., Lee, T.G., Wie, B.A., Lee, S.B., Park, S.H., and Chang, K.H. (1994). Initial and follow-up brain MRI findings and correlation with the clinical course of Wilson disease. Neurology 44:1064-1068.
84. Ropper, A.H., Hatten, H.P., and Davis, K.R. (1979). Computed tomography in Wilson Disease: Report of 2 cases. Ann. Neurol. 5(1):102-103.
85. Roselli, M. (1987) Wilson's disease, a reversible dementia: case report. J Clin. Exp Neuropsychol. 9(4):399-406.
86. Rothfus, W.E., Hirsch, W.L., Malatack, J.J., and Bergman I. (1988). Improvement of cerebral CT abnormalities following liver transplatation in a patient with Wilson Disease. J. Comput. Assisted Tomography 12(1):138-140.
87. Scheinberg, I. H., and Sternlieb, I. (1984). Major Problems in Internal Medicine, Vol. XXIII; Wilson's Disease, W. B. Saunders Company, Philadelphia.
88. Scheinberg, I.H., and Sternlieb, I. (1995). Treatment of neurologic manifestations of Wilson's disease (letter). Arch. Neurol. 52:339-340.
89. Selekler, K., Kansu, T. and Zileli T. (1981) Computed tomography in Wilson Disease. Arch. Neurol. 38:727-728.
90. Sener, R.N. (1993). The claustrum on MRI: normal anatomy, and the bright claustrum as a new sign in Wilson's disease. Pediatr. Radiol. 23:594-596.
91. Shiraki, H. (1968). Comparative neuropathologic study of Wilson's Disease and other types of hepatocerebral disease. Birth Defects IV(2):64-73.
92. Shoulson, I., Goldblatt, D., Plassche, W., and Wilson, G. (1983). Some therapeutic observations in Wilson's Disease. Adv. Neurol. 37:239-245.
93. Singcharoen, T., Chakkaphak, K., and Udompanich, O. (1991). Unusual magnetic resonance findings in Wilson's disease. Br. J. Radiol. 64:752-754.
94. Smith, F.W., Gemell, H.G., Sharp, P.F. and Besson J.A.O. (1988). Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br. J. Radiol. 61:914-920.
95. Snow, B.J., Bhatt, M., Martin, W.R.W., Li, D., and Calne, D.B. (1991). The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J. Neurol. Neurosurg. Psychiatry 54:12-17.
96. Starosta-Rubinstein, S., Young, A.B., Kluin, K., Hill, G., Aisen, A.M., Gabrielsen, T., and Brewer, G.J. (1987). Clinical assessment of 31 patients with Wilson's Disease. Arch. Neurol. 44:365-370.
97. Sternlieb, I. (1990). Perspectives on Wilson's disease. Hepatolagy 12(5):1235-1239.
98. Takano, K., Kuroiwa, Y., Shimada, Y., Mannen, T., and Toyokura Y. (1983). CT manifestations of cerebral white matter lesion in Wilson Disease. Ann. Neurol. 13(1):108-109.
99. Tallis, G.A., Kitchener, M.I., and Thomas, A.C. (1990). Hyperparathyroidism in a patient with Wilson's disease. Clin. Chem. 36(3):568-570.
100. Tanzi, R.E., Petrukhin, K., Chernow, I., Pellequer, J.L., Wasco, W., Ross, B., Romano, D.M., Parano, E., Pavone, L., Brzustowicz, L.M., Devoto, M., Peppercorn, J., Bush, A.L, Sternlieb, I., Pirastu, M., Gusella, J.F., Evgrafov, O., Penchaszadeh, G.K., Honig, B., Edelman, I.S., Soares, M.B., Scheinberg, I.H., and Gilliam, T.C. (1993). The Wilson disease gene is a copper transporting ATPase wih homology to the Menkes disease gene. Nat. Genet. 5:344-350.
101. Thuomas, K.A., Aquilonius, S.M., Bergstrom, K., and Westermark, K. (1993). Magnetic resonance imaging of the brain in Wilson disease. Neuroradiology 35:134-141.
102. Tingey, A.H. (1937). The iron, copper and manganese content of the human brain. J. Ment. Sci. 83:452-460.
103. Uzman, L.L. (1956). Histochemical localization of copper with rubeanic acid. Lab. Invest. 5(3):299-305.
104. Van den Berg, J.S.P., Hoogenraad, T.U., Duyn, J.A., Verbeeten, jr. B., Aalfs, C.M., and De Visser, M. (1995). Ziekte van Wilson; ontmaskering met behulp van kernspinresonantie-tomography. Ned. Tijdschr. Geneeskd. 139(15):796-799.
105. Van den Heuvel, A.G., Van Wassenaer-van Hall, H.N., Hoogenraad, T.U., Mali, W.P.T.M. (1995). Hepatic or copper related encephalopathy in Wilson's disease: can MR differentiate between them? (abstract). Eur. Radiol. 5(suppl.):S140.
106. Van der Knaap, M.S., and Valk, J. (1995). Wilson Disease. In (M.S. Van der Knaap, and J. Valk, eds), Magnetic Resonance of Myelin, Myelination and Myelin Disorders (2nd ed.). Springer-Verlag, Berlin, pp. 246-251.
107. Van Wassenaer-van Hall, H.N., Van den Heuvel, A.G., Jansen, G.H., Hoogenraad, T.U., and Mali, W.P.T.M. (1995). Cranial MR in Wilson Disease: Abnormal white matter in extrapyramidal and pyramidal tracts. Am. J. Neuroradiol. 16:2021-2027.
108. Van Wassenaer-van Hall, H.N., Van den Heuvel, A.C., Algra, A, Hoogenraad, T.U., and Mali, W.P.T.M. (1996a). Wilson Disease: Findings at MR imaging and CT of the Brain with Clinical Correlation. Radiology 198:531-536.
109. Van Wassenaer-van Hall, H.N., Van den Heuvel, A.G., Hoogenraad, T.U., and Mali, W.P.T.M. (1996b). Wilson disease: Long- term follow- up with brain MRI during zinc therapy. In: Wilson Diseae: Magnetic Resonance Findings (Dissertation, University of Utrecht), Feba Druk DV, Enschede:pp 39-50.
110. Victor, M. (1974). Neurologic changes in liver disease. In (F. Plum, ed.), Brain Dysfunction in Metabolic Disorders, Vol 53, Raven Press, New York, pp. 1-12.
111. Vymazal, J., Bulte, J.W.M., Frank, J.A., Di Chiro, G., and Brooks, R.A. (1993). Frequency dependence of MR relaxation times. I. Paramagnetic ions. J. Magn. Reson. Imaging 3:637-640.
112. Walshe, J.B. (1986). Wilson's disease. In (P.J. Vinken, G.W. Bruyn, H.L. Klawans, eds), Handbook of Clinical Neurology, Vol 5 (49), Elsevier, New York, 223-238.
113. Walshe, J.M., and Gibbs, K.R. (1987). Brain copper in Wilson's disease (letter). Lancet 2:1030.
114. Walshe, J.M., and Yealland, M. (1993). Chelation treatment of neurological Wilson's disease. Q. J. Med. 86:197-204.
115. Warren, P.J., Earl, C.J., and Thompson, R.H.S. (1960). The distribution of copper in the human brain. Brain 83:709-717.
116. Willeit, J., Kieschl, S.G., Birbamer, G., Schmidauer, Ch., Felber, St., Aichner, F., Saltvari, L., Metzler, R., and Judmaier, G. (1992). Morbus Wilson mit primarer ZNS-manifestation - aktueller stand in diagnostik and therapy. Fortschr. Neurol. Psychiat. 60:237-245.
117. Williams, J.B., and Walshe, J.M. (1981). Wilson's disease: an analysis of the cranial computerized tomography appearances found in 60 patients and the changes in response to treatment with chelating agents. Brain 104:735-752.
118. Wilson, S.A.K. (1912). Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain 34:295-507.
119. Yuh, W.T.C., and Flickinger, F.W. (1988). Unusual MR findings in CNS Wilson disease (letter) . Am. J. Roentgenol. 151:834.